Digital Therapeutics (DTx): Clinically validated software-based medical intervention. Prescription or OTC. Behavior·cognition·lifestyle change induction. Drug supplement or replacement. FDA·MFDS approval required.

“Prescribed apps” — DTx established as medical category since late 2010s. From 2017 Pear Therapeutics reSET (addiction) FDA first approval to 2026 MamaLift Plus first maternal mental health DTx evolution. L72 MamaLift Plus = digital solution enters maternal mental health blind spot. After drug·stimulation·psychedelic, digital becomes 4th psychiatric tool.

What it is

DTx: Clinically validated software medical intervention, prescription (PDT) or OTC, standalone or drug combo, FDA·MFDS approval (medical device SaMD or new category)

Distinction:

DTx: Clinically validated·approved·prescribed (medical device)
General health apps: No clinical validation (Apple Health·Fitbit)
mHealth: General digital health
Telehealth: Remote consultation

Mechanism

Core mechanisms: CBT digitization, behavior change induction (tracking·alerts), gamification (Akili EndeavorRx), AI personalization (MamaLift Plus), clinician integration (dashboard·sharing)

Clinical effects: Drug replacement or supplement, ↓ side effects (software), daily possible (home·on-the-go), ↓ cost (long-term)

FDA DTx Approval Flow

2017: First PDT FDA approval — Pear Therapeutics reSET (addiction), prescription, follow-up: reSET-O (opioid)

2018: Clinical validation strengthened — Pear Therapeutics Somryst (insomnia), CBT-I digital

2020: Pediatric indications — Akili EndeavorRx (8~12 yr ADHD), gamification, first game-style FDA approval

2021: Chronic disease — Welldoc BlueStar (diabetes), clinician dashboard

2023: Depression·anxiety — Big Health Sleepio·Daylight (insomnia·anxiety), UK NICE recommended

2026: First maternal mental health — Curio MamaLift Plus (PPD) — L72

Clinical Validation - RCT Required

FDA requirements: Clinical trials (RCT), effect proof (vs placebo or standard care), safety confirmation, usability (UX·access)

Example - MamaLift Plus: RCT PPD patients, EPDS 4+ improvement, vs placebo (control app), 8~12 wk program

L72 MamaLift Plus - First Maternal Mental Health

Curio Digital Therapeutics 2026.4: FDA first maternal mental health DTx, PPD mild·moderate, prescription, 8~12 wk CBT-PPD, TEMPO pilot (CMS Medicare/Medicaid)

Meaning: Drug aversion·breastfeeding concerns blind spot, maternal death #1 cause (suicide) response, global model expansion

Korean DTx Status

Korean MFDS Guideline (2020~): Digital therapeutic classification·approval, clinical trial requirement, partial insurance

Korean First DTx (2024): Aimmed Soms: depression, CBT-based, prescription, partial insurance

Korea ongoing: Welt (sleep), HealthSet (diabetes), Doctor Park (rehab)

DTx vs General Apps - Differences

General health apps: No clinical validation, self-use, Apple Health·Fitbit·MyFitnessPal, info·tracking-centered

DTx: Clinical validation·FDA·MFDS approval, prescription or OTC, medical device SaMD classification, effect proof·side effect monitoring, clinician integration

Pregnancy·Postpartum DTx Trends (L72)

MamaLift Plus: PPD, 8~12 wk CBT-PPD, first maternal mental health DTx

Other pregnancy·postpartum DTx: Mahmee (maternal monitoring), Peanut (social·mental), BloomzMD (coaching), Curio Wave (anxiety)

L66~L72 Digital Therapy Dimension

Digital tools establish across diagnostic·stimulation·treatment multi-axis. L65 Oura·wearable + L70 SAINT TMS + L70 WHOOP 11 + L72 MamaLift Plus (DTx).

Prescription vs OTC Digital Therapy

PDT (Prescription): Doctor prescription needed, insurance coverage (partial), rich clinical validation, e.g., Pear reSET·MamaLift Plus

OTC: No prescription, pharmacy·online self-purchase, simple indications, e.g., Calm·Headspace (not formal DTx)

FAQ

Q. Apps prescribed like drugs really effective? A. FDA·MFDS approved DTx proven by RCT. But not instant like drugs. 8~12 wk consistency core. Effect by indication·severity.

Q. DTx instead of drug = insurance coverage? A. Some insurance coverage (Korea·US). MamaLift Plus = TEMPO pilot expands Medicare/Medicaid. Some Korean DTx insurance.

Q. Difference from general apps? A. Clinical validation·FDA·MFDS approval = DTx. General apps no validation. Effect·safety difference.

Q. How do doctors prescribe? A. Prescription → digital code or app activation. Clinician dashboard for progress monitoring.

Q. Korean DTx availability? A. Soms (depression)·some psychiatry·rehab. OB-GYN PPD DTx = 2027~2028 expected.

PDT (Prescription Digital Therapeutic)
SaMD (Software as a Medical Device)
CBT (Cognitive Behavioral Therapy)
CBT-I: Insomnia CBT
CBT-PPD: Postpartum CBT

Conclusion

DTx = prescribed apps medical category. From FDA 2017 first approval to 2026 maternal mental health evolution. L72 MamaLift Plus = PPD blind spot release. L72 = 45 pillars + digital verification·establishment dimension (DTx 1st axis). Korean adoption progressing. After drug·stimulation·psychedelic, digital = 4th psychiatric tool.

Digital Therapeutics (DTx) — Prescribed Apps. FDA-Approved Software Medical Intervention